This past Thursday, Congress passed the Sunscreen Innovation Act. The bill’s purpose is to speed up the FDA review process of active sunscreen filter ingredients that are already being used in sunscreens sold in Europe and Canada but not in the USA. Consider this a big win for the all Americans and the skin care industry.
The FDA has been known to drag their feet when it comes to approving pending sunscreen ingredients. The last one approved by them was way back in 2006! So there has been no meaningful innovation in terms of how sunscreen products work to block the harmful UVA/UVB sunrays for almost a decade. The new law requires that the FDA reduce the bureaucratic review process of new sunscreen applications, as well as streamline the review of applications for ingredients that have already been used safely for at least 5 years in another country.
With new skin cancer rates hitting two million cases and almost ten thousand deaths a year, the Sunscreen Innovation Act will pave the way for Americans to fight a highly preventable disease. The FDA has only approved 3 active sunscreen ingredients that block UVA, the rays that penetrate deeper into the skin which can cause premature aging and skin cancer, while the European Union has 7 approved ingredients.
Americans can be assured that the skincare industry will be fast on producing any new sunscreen products with the new actives once approved by the FDA. The companies whose ingredients have been awaiting a FDA review are Ashland Inc., BASF, and L’Oreal.